SINGLE DOMAIN ANTIBODIES AND BIOENGINEERING DRUGS ON THEIR BASIS: NEW OPPORTUNITIES FOR DIAGNOSTICS AND THERAPY
Almost 20 years ago, a unique class of antibodies devoid of L chains was discovered in Camelidae blood serum. Only one variable domain is responsible for antigen recognition in these unusual antibodies. A recombinant protein, which is analogue to such antigen-recognizing variable domain was called t...
Guardado en:
Autores principales: | E. N. Gorshkova, E. A. Vasilenko, S. V. Tillib, I. V. Astrakhantseva |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d2b367f078848c98022a2764ff53ec5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A comprehensive comparison between camelid nanobodies and single chain variable fragments
por: Yasaman Asaadi, et al.
Publicado: (2021) -
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
por: Elisa C. Toffoli, et al.
Publicado: (2021) -
A NEW METHOD BASED ON THE USE OF IMMOBILIZED SINGLE-DOMAIN ANTIBODIES TO REMOVE CERTAIN MAJOR PROTEINS FROM BLOOD PLASMA HELPS TO REDUCE NONSPECIFIC SIGNAL IN AN IMMUNOASSAY
por: O. S. Goryainova, et al.
Publicado: (2019) -
Determinación de anticuerpos anti-transglutaminasa en el diagnóstico de enfermedad celíaca
por: Weitz V,Juan Carlos, et al.
Publicado: (2003) -
Anticuerpos anti-transglutaminasa tisular: ¿una mejor prueba para detectar transgresiones menores de la dieta en pacientes celíacos?
por: Gotteland R,Martin, et al.
Publicado: (2003)